Context TherapeuticsCNTX
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 79 institutions reported holding Context Therapeutics Inc. (CNTX) in their 13F filings, up 19 from Q1 2026. 36 opened new positions and 15 sold out. The largest holders were Nextech Invest Ltd. ($4.1M), Deep Track Capital, LP ($4.1M) and Soleus Capital Management, L.P. ($3.9M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Context Therapeutics Inc.
- CUSIP
- 21077P108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 36 | $2.2M |
| Exits | 15 | $16.8M |
All 13F filers, Q1 2026 → Q2 2026: 14,494,174 shares bought and 25,756,384 shares sold, net −11,262,210 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 79 holders
| Nextech Invest Ltd. | 0.20% | No change | 7,419,355 | $4.1M |
| Deep Track Capital, LP | 0.06% | No change | 7,419,355 | $4.1M |
| Soleus Capital Management, L.P. | 0.13% | Add +1.4% | 7,063,141 | $3.9M |
| BlackRock, Inc. | 0.00% | Add +628.6% | 6,169,250 | $3.4M |
| Avidity Partners Management LP | 0.44% | No change | 4,998,267 | $2.8M |
| Franklin Resources Inc. | 0.00% | No change | 3,803,338 | $2.1M |
| Vanguard Capital Management LLC | 0.00% | Add +0.0% | 3,432,052 | $1.9M |
| Octagon Capital Advisors LP | 0.16% | Reduce -41.9% | 3,050,000 | $1.7M |
| Blue Owl Capital Holdings LP | 0.25% | Reduce -42.4% | 2,934,015 | $1.6M |
| TCG Crossover Management, LLC | 0.04% | No change | 2,682,696 | $1.5M |
| Geode Capital Management, LLC | 0.00% | Add +203.2% | 1,830,309 | $1.0M |
| State Street Corp. | 0.00% | Add +505.3% | 1,413,428 | $783K |
| MPM Bioimpact LLC | 0.04% | Reduce -87.8% | 1,299,046 | $720K |
| Renaissance Technologies | 0.00% | Add +469.1% | 1,041,399 | $577K |
| Acadian Asset Management LLC | 0.00% | New | 1,010,904 | $559K |
| ADAR1 Capital Management, LLC | 0.02% | Add +113.9% | 750,969 | $416K |
| Jane Street Group, LLC | 0.00% | Add +47.7% | 645,209 | $357K |
| Vanguard Portfolio Management LLC | 0.00% | New | 638,878 | $354K |
| Northern Trust Corp. | 0.00% | Add +496.2% | 615,576 | $341K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +27.1% | 433,888 | $240K |
| Marshall Wace, LLP | 0.00% | Reduce -87.0% | 384,528 | $211K |
| XTX Topco Ltd | 0.00% | New | 294,301 | $163K |
| Qube Research & Technologies Ltd | 0.00% | Add +2155.4% | 257,068 | $142K |
| Charles Schwab Investment Management Inc. | 0.00% | New | 227,850 | $126K |
| Pathstone Holdings, LLC | 0.00% | Add +94.9% | 214,875 | $119K |
| Timothy G. Youngquist 2020 Irrevocable Trust | 0.02% | New | 198,384 | $110K |
| Graham Capital Management, L.P. | 0.00% | New | 163,527 | $91K |
| Gsa Capital Partners LLP | 0.01% | New | 159,804 | $89K |
| Millennium Management | 0.00% | Reduce -89.7% | 147,287 | $82K |
| New York State Common Retirement Fund | 0.00% | New | 135,300 | $75K |
| Private Advisor Group, LLC | 0.00% | New | 125,852 | $70K |
| HighTower Advisors, LLC | 0.00% | Reduce -0.2% | 125,852 | $70K |
| Nuveen, LLC | 0.00% | New | 125,518 | $70K |
| Bank of New York Mellon Corp | 0.00% | New | 109,362 | $61K |
| Natixis | 0.00% | New | 97,109 | $55K |
| Clear Harbor Asset Management, LLC | 0.00% | No change | 92,804 | $51K |
| Deutsche Bank AG | 0.00% | New | 90,882 | $50K |
| Wells Fargo & Company | 0.00% | New | 84,981 | $47K |
| Woodline Partners LP | 0.00% | Reduce -68.8% | 77,933 | $43K |
| T. Rowe Price Associates Inc. | 0.00% | New | 77,538 | $43K |
| Citigroup Inc. | 0.00% | Add +477.3% | 70,323 | $39K |
| Rhumbline Advisers | 0.00% | New | 69,844 | $39K |
| Two Sigma Securities, LLC | 0.00% | Add +388.7% | 61,444 | $34K |
| Velan Capital Investment Management LP | 0.02% | Reduce -40.3% | 59,700 | $33K |
| Alliancebernstein L.P. | 0.00% | New | 59,000 | $33K |
| Bank of America Corp. | 0.00% | Reduce -53.5% | 53,402 | $30K |
| Squarepoint Ops LLC | 0.00% | New | 52,709 | $29K |
| Invesco Ltd. | 0.00% | New | 50,617 | $28K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | New | 42,898 | $24K |
| JPMorgan Chase & Co. | 0.00% | Add +270.6% | 38,621 | $22K |
| Cerity Partners LLC | 0.00% | Add +100.0% | 40,000 | $22K |
| Morgan Stanley | 0.00% | Add +275.9% | 34,121 | $19K |
| Verdad Advisers, LP | 0.02% | New | 33,900 | $19K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2280.8% | 29,331 | $16K |
| UBS Group AG | 0.00% | Add +355.4% | 28,183 | $16K |
| Barclays PLC | 0.00% | New | 27,504 | $15K |
| Two Sigma Investments, LP | 0.00% | New | 25,941 | $14K |
| Citadel Advisors | 0.00% | Reduce -87.6% | 17,338 | $10K |
| Susquehanna International Group, LLP | 0.00% | Reduce -98.5% | 16,722 | $9K |
| SG Americas Securities, LLC | 0.00% | New | 15,462 | $9K |
| BNP Paribas Financial Markets | 0.00% | New | 14,233 | $8K |
| Prudential Financial Inc. | 0.00% | New | 13,390 | $7K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 12,612 | $7K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -95.7% | 12,389 | $7K |
| ProShare Advisors LLC | 0.00% | New | 12,199 | $7K |
| State of Wisconsin Investment Board | 0.00% | New | 12,000 | $7K |
| Pale Fire Capital SE | 0.00% | New | 11,796 | $7K |
| Osaic Holdings, Inc. | 0.00% | No change | 10,500 | $6K |
| Legal & General Group Plc | 0.00% | New | 9,074 | $5K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 8,455 | $5K |
| Russell Investments Group, Ltd. | 0.00% | New | 7,450 | $4K |
| FNY Investment Advisers, LLC | 0.00% | No change | 6,000 | $3K |
| Royal Bank of Canada | 0.00% | New | 3,015 | $2K |
| FMR LLC | 0.00% | New | 2,594 | $1K |
| Strive Financial Group ,LLC | 0.00% | No change | 1,700 | $942 |
| Farther Finance Advisors, LLC | 0.00% | No change | 1,500 | $831 |
| McGuire Capital Advisors Inc. | 0.00% | New | 393 | $218 |
| Sterling Capital Management LLC | 0.00% | New | 327 | $181 |
| SBI Securities Co., Ltd. | 0.00% | No change | 78 | $43 |
"% of holder's portfolio" is CNTX's weight in each manager's 13F, not the share of Context Therapeutics Inc. the manager owns.